Kim Jin Hyoung, Shin Ji Hoon, Song Ho-Young, Shim Tae Sun, Yoon Chang Jin, Ko Gi-Young
Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Poongnap-dong, Songpa-gu, Seoul 138-736, South Korea.
AJR Am J Roentgenol. 2007 Apr;188(4):1033-8. doi: 10.2214/AJR.06.0888.
The purpose of our study was to evaluate long-term results and identify factors affecting airway patency after temporary placement of a covered, retrievable nitinol stent for benign tracheobronchial strictures.
Polyurethane or polytetrafluoroethylene (PTFE)-covered retrievable expandable nitinol stents were placed fluoroscopically in 24 patients with benign tracheobronchial strictures. Improvement in respiratory status and complications were evaluated. Maintained patency of airway after temporary stenting was calculated and compared between the 2- and 6-month stenting groups. Factors for maintained patency after temporary stenting were evaluated.
A total of 30 stents were successfully placed and well tolerated in 24 patients. Tissue hyperplasia, stent migration, and bronchial obstruction of the left upper lobe occurred in 36.7%, 13.3%, and 3.3% of patients, respectively. All stents were successfully removed electively either 2 (n = 12) or 6 (n = 12) months after placement or when complications occurred (n = 6). During the follow-up period (mean, 24 months), dyspnea recurred in 15 of the 24 patients. The 6-month stenting group showed a lower recurrence rate (41.7% vs 83.3%, p = 0.045) and a better mean maintained patency (39.7 +/- 7.8 vs 9.4 +/- 5.4 months, p = 0.001) than the 2-month stenting group. Multivariate analysis showed that duration of stent placement (p = 0.002) and the occurrence of tissue hyperplasia (p = 0.026) were associated with maintained patency after temporary stenting.
Temporary placement of a covered, retrievable, expandable nitinol stent may be a safe and effective treatment for benign tracheobronchial strictures during the period the stent is in place. A high symptomatic recurrence rate of 62.5% was found after stent removal. Shortterm placement of the stent and tissue hyperplasia were associated with decreased airway patency.
本研究旨在评估带膜可回收镍钛合金支架临时置入治疗良性气管支气管狭窄后的长期效果,并确定影响气道通畅性的因素。
在24例良性气管支气管狭窄患者中,通过荧光透视法置入聚氨酯或聚四氟乙烯(PTFE)覆盖的可回收可扩张镍钛合金支架。评估呼吸状况的改善情况及并发症。计算并比较2个月和6个月支架置入组临时支架置入后气道的维持通畅情况。评估临时支架置入后维持通畅的因素。
24例患者共成功置入30枚支架,耐受性良好。分别有36.7%、13.3%和3.3%的患者发生组织增生、支架移位和左上叶支气管阻塞。所有支架均在置入后2个月(n = 12)或6个月(n = 12)或出现并发症时(n = 6)成功择期取出。在随访期(平均24个月)内,24例患者中有15例再次出现呼吸困难。6个月支架置入组的复发率较低(41.7% 对83.3%,p = 0.045),平均维持通畅时间更长(39.7 +/- 7.8对9.4 +/- 5.4个月,p = 0.001),优于2个月支架置入组。多因素分析显示,支架置入时间(p = 0.002)和组织增生的发生(p = 0.026)与临时支架置入后维持通畅有关。
带膜可回收可扩张镍钛合金支架的临时置入在支架置入期间可能是治疗良性气管支气管狭窄的一种安全有效的方法。支架取出后症状复发率高达62.5%。支架的短期置入和组织增生与气道通畅性降低有关。